Long-term enzyme replacement therapy (ERT) to treat people with Pompe disease loses effectiveness in maintaining walking ability, muscle strength, and lung function, a new study shows. Despite these results, ERT improved lung function when compared to the predicted outcome without ERT, and some patients responded…
treatment
Adding carvedilol, the active compound of a blood pressure medicine, to enzyme replacement therapy (ERT) for Pompe disease can improve its effectiveness in reaching and strengthening skeletal muscles, a study in mice suggests. This finding, “Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with…
Managing Breathing Problems in Late-onset Pompe Disease
Pompe is a type of glycogen storage disease in which a complex sugar molecule known as glycogen builds up within cells, especially in the muscle cells. A defect in the GAA gene causes low production of the acid alpha-glucosidase enzyme that is needed to break down glycogen into…
AT-GAA Continues to Induce Motor, Lung Improvements in Pompe Adult Patients, Phase 1/2 Study Shows
Amicus Therapeutics’s investigational therapy AT-GAA (ATB200/AT221) continues to show promise as a safe and effective treatment for adults with Pompe disease, according to the latest results from an ongoing Phase 1/2 clinical trial. Pompe disease is caused by acid alpha-glucosidase (GAA) enzyme deficiency, leading to the build-up of glycogen…
The use of enzyme replacement therapy is safe and effective in Japanese people living with Pompe disease, a new study shows. Titled “Long-Term Observation of the Safety and Effectiveness of Enzyme Replacement Therapy in Japanese Patients with Pompe Disease: Results From the Post-marketing Surveillance,” the study…
Make the Most of Your Doctor’s Visit When You Have Pompe Disease
Rare genetic diseases such as Pompe disease pose a challenge in effectively communicating your concerns to the doctor. Here are some tips to make the most of your doctor’s visit. Make sure you consult the right doctor Pompe disease is a rare genetic disorder, so not all doctors are…
Natural genetic variations, or polymorphisms, in the ACE gene do not account for the large variability in disease course, or the response to enzyme replacement therapy (ERT) observed among children and adults with Pompe disease, a study suggests. More research is needed to identify the…
Dietary Considerations in Pompe Disease
Pompe disease is a rare genetic disorder caused by mutations in the GAA gene. It is characterized by the buildup of glycogen, a complex sugar molecule, in cells and tissues due to the absence or improper functioning of an enzyme called acid alpha-glucosidase. Changes to diet and…
Developing gene therapies for rare diseases is one thing. Creating gene-edited “designer babies” is quite another. German legal expert Timo Minssen outlined the potentially explosive ethical landmines surrounding such issues during a recent talk at the New York Genome Center. Minssen directs the Center for Advanced Studies in…
Pharmaceutical executives rarely make for a sympathetic Hollywood medical drama. But John Crowley did, and in the nearly 10 years since the release of “Extraordinary Measures” — a tearjerker starring Brendan Fraser as Crowley and Harrison Ford as short-tempered scientist Robert Stonehill — biotech has seen a huge transformation, both…
Recent Posts
- Late-onset Pompe disease diagnosed nearly 20 years after symptoms began
- No Pompe journeys are the same, but we don’t have to walk this road alone
- Patient interviews reveal experiences with Pompe treatment and trials
- My daughter with Pompe disease is brave, but every kid has their limits
- Study maps molecular changes in Pompe muscle cells